It’s unclear how much such a pill would cost, but Novo Nordisk’s Ozempic and Wegovy shots currently go for several hundred ...

The Danish drugmaker said a clinical trial showed participants who got a pill form of Wegovy lost an average of 16.6 percent ...

New results from a survey of 550 Wegovy users found patients reported a major drop in "food noise," or intrusive thoughts ...

"That's an easy move to make out of the gate, but it's also unusual at Novo, and it's piqued investor interest," said ...

Danish multinational pharmaceutical company Novo Nordisk’s obesity drug Wegovy (semaglutide 2.4 mg) cut risk of heart attack, ...

Novo Nordisk's pill version of Wegovy could be just as effective as the injectable shot, according to new clinical trial data ...

Novo Nordisk's experimental Wegovy pill showed a 16.6% weight-loss in a late-stage study, according to data published in The ...

Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form. Novo Nordisk says its oral semaglutide pill led to "significant weight loss" in a trial.

Hi, this is Naomi. I’m off to Vienna for a diabetes conference, and I’ve come across a lesser-known GLP-1 side effect. More ...

The company’s experimental daily pill helped patients lose an average 16.6% of their weight, according to late-stage trial, and it could be approved in the U.S. by the end of the year.

The number of people who reported experiencing constant thoughts about food declined by 46% after starting treatment with ...

Among 77,310 adults without diabetes who began taking semaglutide after it was approved for weight loss, 40,262 (52%) were no ...